Biosimilars Market by Product & Manufacturing Type
Increasing demand for biosimilar drugs due to their cost-effectiveness, increasing incidences of chronic diseases, and strategic collaborations resulting in enhanced productivity and clinical trial activities are the key drivers for Biosimilars Market.
Breakdown of Primary Interviews
The products in biosimilars market include non-glycosylated proteins, recombinant glycosylated proteins, and recombinant...
Biosimilars Market by Product, manufacturing Type & Disease – 2023
The biosimilars market is expected to reach USD 23.63 billion by 2023 from USD 5.95 billion in 2018, at a CAGR of 31.7% during the forecast period. Growth in this market is mainly driven by factors such as rising incidence of chronic diseases and increasing demand for biosimilar drugs due to their cost-effectiveness.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=40
On...